Intelligence · Clinical Development
Pipeline search results
Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Hepatitis A Vaccine
Takeda
Healthy Volunteers
1 trial -
ION-682884
IONIS PHARMACEUTICALS INC
Healthy Volunteers
1 trial -
IW-6118
IRONWOOD PHARMACEUTICALS INC
Healthy
1 trial -
Low Dose TP-05
Tarsus Pharmaceuticals
Healthy Volunteer
1 trial -
MR-130A-01
Mylan Pharma UK
Investigation of maintenance of ovulation inhibition after intentional application errors for indication of contraception in healthy subjects
1 trial -
Naproxen
Protalix BioTherapeutics
Healthy Volunteers
1 trial -
NoV Placebo-matching Saline
Takeda
Healthy Volunteers
1 trial -
NoV Vaccine
Takeda
Healthy Volunteers
1 trial -
PRENUMBRA
Clinuvel Europe Limited
Healthy volunteers
1 trial -
Placebo
Vistagen Therapeutics
Healthy
1 trial -
Psilocybin
BRIGHT MINDS BIOSCIENCES INC.
Healthy
1 trial -
Purified Inactivated Zika Virus Vaccine (PIZV)
Takeda
Healthy Volunteers
1 trial -
TD-1211
Theravance Biopharma Ireland Umited
Healthy
2 trials -
TDV
Takeda
Healthy
1 trial -
Tafenoquine
60 DEGREES PHARMACEUTICALS, INC.
Healthy Volunteers
1 trial -
Tradipitant
Vanda Pharmaceuticals Netherlands B.V.
Healthy Volunteer
1 trial -
Vodobatinib (K0706) capsules
Advanced Accelerator Applications
Healthy (For Part A)
1 trial -
casirivimab+imdevimab
Regeneron UK Limited
Healthy
2 trials -
039(C/a)MD23341
Lacuna Pharma Pty Ltd
Intended indication: Major Depressive Disorders with and without anxiety, Healthy volunteers, therapeutic indication not studied
1 trial -
100 mg GLPG1205
Lakefront Biotherapeutics NV
Healthy
1 trial -
100 mg dose of [14C] GLPG0634
Lakefront Biotherapeutics NV
Healthy
1 trial -
1019/25
Laboratorios Tillomed Spain S.L.U
Bioavailability study in healthy volunteers under fed conditions.
1 trial -
1028/25
Lacuna Pharma Pty Ltd
Not applicable (submitted trial is a BE study in healthy subjects).
1 trial -
1046/25
Lacuna Pharma Pty Ltd
Not applicable (submitted trial is a BE study in healthy subjects.
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.